ERBB2 and breast carcinoma: IHC assays revealed that MCM3 protein was remarkably upregulated in luminal breast cancer, HER2+ breast cancer, and TNBC tissues (p < 0.01, Fig. 3B), and MCM3 expression was highest in TNBC tissues.